Skip to main content
Top
Published in: Documenta Ophthalmologica 3/2007

01-05-2007 | Case Report

Branch retinal artery occlusion associated with compound heterozygous genotype for methylenetetrahydrofolate reductase

Authors: Martin Heur, Gregory S. Kosmorsky, Neal S. Peachey, Elisa Bala

Published in: Documenta Ophthalmologica | Issue 3/2007

Login to get access

Abstract

We present a case in which mfERG and OCT helped to make a diagnosis of an old BRAO in the setting of compound heterozygous MTHFR genotype. A 44-year-old woman presented for evaluation of a 10 month history of persistently cloudy vision OS. She had been worked up previously for MS versus BRAO, and she was on coumadin, folate, and multivitamin at the time of presentation. The patient has a fraternal twin sister who was diagnosed with MS. Dilated fundus examination OS showed subtle inferior optic atrophy with slight narrowing of the inferotemporal retinal artery, and HVF test revealed a superonasal depression OS. mfERG also showed superonasal depression OS. Retinal origin of the chief complaint was further confirmed by OCT, which showed thinning of the NFL in the corresponding region of the retina OS. Coagulopathy evaluation revealed C677T/A1298C compound heterozygous genotype for MTHFR, and plasma homocysteine level after 6 months of folate and multivitamin supplementation was 10 μM (reference range 4–10 μM). The patient was diagnosed with BRAO and maintained on coumadin therapy.
Literature
1.
go back to reference Blice JB, Brown GC (1999) Retinal vascular occlusive disease. In: Spaide RF (eds) Diseases of the retina and vitreous. W.B. Saunders, Philadelphia, pp 109–127 Blice JB, Brown GC (1999) Retinal vascular occlusive disease. In: Spaide RF (eds) Diseases of the retina and vitreous. W.B. Saunders, Philadelphia, pp 109–127
2.
go back to reference Brown GC (1999) Retinal artery occlusive disease. In: Guyer DR, Yanuzzi LA, Chang S, Shields JA (eds) Retina-Vitreous-Macula. W.B. Saunders, Philadelphia, pp 271–285 Brown GC (1999) Retinal artery occlusive disease. In: Guyer DR, Yanuzzi LA, Chang S, Shields JA (eds) Retina-Vitreous-Macula. W.B. Saunders, Philadelphia, pp 271–285
3.
go back to reference McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111–128PubMed McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111–128PubMed
4.
go back to reference Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324:1149–1155PubMedCrossRef Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324:1149–1155PubMedCrossRef
5.
go back to reference Wenzler EM, Rademakers AJ, Boers GH, Cruysberg JR, Webers CA, Deutman AF (1993) Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol 115:162–167PubMed Wenzler EM, Rademakers AJ, Boers GH, Cruysberg JR, Webers CA, Deutman AF (1993) Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol 115:162–167PubMed
6.
go back to reference Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ (1995) Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 56:142–150PubMed Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ (1995) Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 56:142–150PubMed
7.
go back to reference van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62:1044–1051PubMedCrossRef van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62:1044–1051PubMedCrossRef
8.
go back to reference Weger M, Stanger O, Deutschmann H, Leitner FJ, Renner W, Schmut O, Semmelrock J, Haas A (2002) The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion. Am J Ophthalmol 134:57–61PubMedCrossRef Weger M, Stanger O, Deutschmann H, Leitner FJ, Renner W, Schmut O, Semmelrock J, Haas A (2002) The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion. Am J Ophthalmol 134:57–61PubMedCrossRef
10.
go back to reference Mathews CK, van Holde KE (1990) Biochemistry. The Benjamin/Cummings Publishing Co, Redwood City Mathews CK, van Holde KE (1990) Biochemistry. The Benjamin/Cummings Publishing Co, Redwood City
11.
go back to reference Boyd S, Owens D, Gin T, Bunce K, Sherafat H, Perry D, Hykin PG (2001) Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion. Br J Ophthalmol 85:1313–1315PubMedCrossRef Boyd S, Owens D, Gin T, Bunce K, Sherafat H, Perry D, Hykin PG (2001) Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion. Br J Ophthalmol 85:1313–1315PubMedCrossRef
12.
go back to reference Choi BO, Kim NK, Kim SH, Kang MS, Lee S, Ahn JY, Kim OJ, Kim S, Oh D (2003) Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions. Thromb Res 111:39–44PubMedCrossRef Choi BO, Kim NK, Kim SH, Kang MS, Lee S, Ahn JY, Kim OJ, Kim S, Oh D (2003) Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions. Thromb Res 111:39–44PubMedCrossRef
13.
go back to reference den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334:759–762CrossRef den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334:759–762CrossRef
14.
go back to reference Chak M, Wallace GR, Graham EM, Stanford MR (2001) Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease. Br J Ophthalmol 85:883–886PubMedCrossRef Chak M, Wallace GR, Graham EM, Stanford MR (2001) Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease. Br J Ophthalmol 85:883–886PubMedCrossRef
15.
go back to reference Woo KS, Chook P, Lolin YI, Sanderson JE, Metreweli C, Celermajer DS (1999) Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol 34:2002–2006PubMedCrossRef Woo KS, Chook P, Lolin YI, Sanderson JE, Metreweli C, Celermajer DS (1999) Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol 34:2002–2006PubMedCrossRef
Metadata
Title
Branch retinal artery occlusion associated with compound heterozygous genotype for methylenetetrahydrofolate reductase
Authors
Martin Heur
Gregory S. Kosmorsky
Neal S. Peachey
Elisa Bala
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
Documenta Ophthalmologica / Issue 3/2007
Print ISSN: 0012-4486
Electronic ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-007-9051-3

Other articles of this Issue 3/2007

Documenta Ophthalmologica 3/2007 Go to the issue